Current Edition

chinese

vTv Therapeutics shares soar on licensing tie-up with Chinese group Newsoara Biopharma

Newsoara will develop vTv Therapeutics’ HPP737 as a new treatment for chronic obstructive pulmonary disease vTv Therapeutics (NASDAQ:VTVT) has sold licensing rights to a rival …

Continue Reading →